ABSTRACT
BACKGROUND: One cause of chronic urticaria is autoreactivity which is diagnosed by detecting autoantibodies against the IgE receptor alpha subunit (anti-Fc R1alpha). OBJECTIVE: To compare the histopathologic features of chronic urticaria patients testing positive for anti-IgE receptor antibody (Ab) to those testing negative. METHODS: Totally, 438 patients with a clinical presentation of chronic urticaria (2011-2013) had anti-IgE receptor Ab tested and 37 of those patients had skin biopsy. We evaluated microscopic features including: spongiosis, dermal edema, presence of mast cells, density of lymphocytic infiltration, predomination of eosinophils/neutrophils; intravascular neutrophils and presence of vasculitis. The aforementioned features were compared between negative and positive anti-IgE receptor Ab groups. RESULTS: Of 37 patients , 69% were women and 31% were men. 49% had positive anti-IgE receptor Ab and 51% had negative anti-IgE receptor Ab. In the positive anti-IgE receptor Ab group, 83% showed intravascular neutrophils. Eosinophil predominance was identified in 72% and neutrophil predominance was identified in 28%. In the negative anti-IgE receptor Ab group, 89% showed intravascular neutrophils. Eosinophil predominance was identified in 53% and neutrophil predominance was identified in 47%. There was no evidence of vasculitis in either group. CONCLUSION: There were no significant histopathologic differences between the anti-IgE receptor Ab positive and negative cases. Therefore, serum testing for anti-IgE receptor Ab is required to identify this subgroup of chronic urticaria patients.
Subject(s)
Antibodies, Anti-Idiotypic/immunology , Autoantibodies/immunology , Receptors, IgE/immunology , Urticaria/immunology , Urticaria/pathology , Adult , Autoimmune Diseases/immunology , Autoimmune Diseases/pathology , Chronic Disease , Eosinophils/immunology , Female , Humans , Male , Mast Cells/immunology , Mast Cells/pathology , Middle Aged , Neutrophils/immunology , Skin/pathologyABSTRACT
Cutaneous meningiomas are divided into three groups. Type I lesions present at birth and are derived from ectopic arachnoid cells. Type II lesions usually present in adults and are derived from arachnoid cells surrounding nerve bundles. Type III lesions are due to direct extension or metastasis from dural-based neoplasms. Dural-based meningiomas are known to express p63. The aim of our study is to examine the expression of p63 in type II and type III meningioma. Two cases of cutaneous meningioma (type II and type III) were evaluated for the expression of p63, EMA, CK 5/6, S100 and CD31. The cells of interest were spindled to epithelioid and arranged in a whorling pattern. Immunohistochemical staining showed expression of EMA and p63 in both cases, while stains for CK 5/6, S100 and CD31 were negative. Among cutaneous tumors, p63 is considered a marker of epithelial derivation, as it is positive in epidermal and adnexal neoplasms. It is important to be aware of p63 expression in the context of cutaneous meningioma to avoid misinterpretation as an epithelial tumor. On the basis of our small study, it is unlikely that p63 expression would be helpful in distinguishing between type II and type III meningioma, as both may be p63-positive.
Subject(s)
Biomarkers, Tumor/biosynthesis , Gene Expression Regulation, Neoplastic , Meningioma , Skin Neoplasms , Transcription Factors/biosynthesis , Tumor Suppressor Proteins/biosynthesis , Aged , Aged, 80 and over , Diagnosis, Differential , Female , Humans , Meningioma/classification , Meningioma/metabolism , Meningioma/pathology , Skin Neoplasms/classification , Skin Neoplasms/metabolism , Skin Neoplasms/pathologyABSTRACT
BRAF inhibition therapy, used to treat melanomas with BRAF mutations, is associated with both neoplastic and non-neoplastic cutaneous side effects including squamous cell carcinomas, warty dyskeratomas, verrucous keratoses, photosensitivity and widespread eruptions that present histopathologically as acantholytic dyskeratosis. We report a case of a patient undergoing BRAF inhibition therapy for disseminated melanoma with a V600E mutation who developed bilateral areolar leiomyomas, one of which was biopsied and the other of which resolved after discontinuation of vemurafenib therapy. To our knowledge, this is the first reported case of a mesenchymal neoplasm developing in association with BRAF inhibition therapy.
Subject(s)
Indoles/adverse effects , Leiomyoma/chemically induced , Leiomyoma/pathology , Melanoma/drug therapy , Neoplasms, Second Primary/pathology , Proto-Oncogene Proteins B-raf/antagonists & inhibitors , Sulfonamides/adverse effects , Aged , Amino Acid Substitution , Humans , Indoles/administration & dosage , Leiomyoma/enzymology , Male , Melanoma/enzymology , Melanoma/pathology , Mutation, Missense , Neoplasms, Second Primary/enzymology , Sulfonamides/administration & dosage , VemurafenibABSTRACT
BACKGROUND: Herpetic dermatitis due to herpes simplex virus (HSV) and varicella zoster virus (VZV) can present with similar clinical and histopathologic features. Further confounding matters, viral cytopathic changes are not always observed in biopsy specimens. Therefore, use of polymerase chain reaction (PCR) analysis can play an integral role in the definitive diagnosis of herpetic dermatitis and in the distinction of HSV-1/HSV-2 from VZV. METHODS: Forty patients with skin biopsies (2004-2011) had PCR analysis performed to detect HSV-1/2 or VZV. Patient demographics, clinical impression and histopathologic characteristics were reviewed and correlated with PCR findings. RESULTS: Overall, there was complete correlation between clinical impression, histopathology and PCR results in 21 of 40 cases. In 19 cases, clinical impression and histopathology were discrepant and in 15 of these cases PCR confirmed HSV or VZV infection. We also describe 3 cases of herpetic dermatitis without viral change that histopathologically demonstrate the pattern of a dermal hypersensitivity reaction. CONCLUSIONS: The results of this study suggest that routine use of PCR for definitive diagnosis of herpetic dermatitis should be considered when there is a clinical suspicion of herpes virus infection, even when there is a lack of specific histopathologic findings. Additionally, a dermal hypersensitivity reaction should be recognized as one histopathologic manifestation of herpes incognito.
Subject(s)
DNA, Viral/analysis , Herpes Simplex/diagnosis , Skin Diseases/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Chickenpox/diagnosis , Chickenpox/virology , Child , Female , Herpes Simplex/virology , Herpes Zoster/diagnosis , Herpes Zoster/virology , Herpesvirus 3, Human/isolation & purification , Humans , Hypersensitivity/diagnosis , Hypersensitivity/virology , Male , Middle Aged , Real-Time Polymerase Chain Reaction , Simplexvirus/isolation & purification , Skin Diseases/virology , Young AdultABSTRACT
BACKGROUND: At our institution, dermatopathology case requisitions are received in hand written form or via electronic medical record (EMR). Categories for requisition data entry include patient demographics, physician name and procedure site/date. Systematic data entry problems potentially cause considerable documentation error, propagate inaccurate patient information and potentially delay billing/revenue collection. METHOD: We compared dermatopathology data entry errors on hand written requisitions to data entry errors using the EMR. A total of 11,475 requisitions (8545 hand written and 2930 EMR) were included in the study (the time frame was 4/1/2011-9/30/2011). RESULTS: For hand written requisitions, there were 258 data entry errors on 8545 specimens (3.0%). For requisitions entered via EMR, there were 113 errors on 2930 specimens (3.9%). Container labeling, which is a hand written process with both requisition methods, was the most common source of error. CONCLUSIONS: Currently, even with an EMR, containers are at least partially hand labeled and 96% of EMR errors occurred during this process. Other EMR data entry errors are extremely uncommon (4/2930 cases). This suggests introduction of a labeling process entirely linked to EMR data entry could nearly eliminate data entry errors. Although this study focused solely on dermatopathology cases, the findings can be extrapolated to all types of specimens.
Subject(s)
Electronic Health Records , Handwriting , Medical Audit , Skin Diseases/diagnosis , Female , Humans , MaleABSTRACT
BACKGROUND: Overlapping histopathologic features of cellular neurothekeoma (CNT) and plexiform fibrohistiocytic tumor (PFHT), when both are predominantly composed of histiocytoid cells, make distinction between these entities challenging. Some have suggested that CNT and PFHT are related entities. No prior study has demonstrated a reliable immunohistochemical panel to differentiate these entities. METHODS: Skin biopsies diagnosed as CNT and PFHT, from 2004 to 2010 were retrieved with accompanying pathology reports. Each case was reviewed by at least 2 dermatopathologists and 2 soft tissue pathologists for confirmation of diagnosis. All cases were then evaluated for immunohistochemical expression of PAX2, NKIC3, CD10, and microphthalmia transcription factor (MiTF). RESULTS: Histopathologically, the histiocytoid areas of each tumor shared similar architecture, demonstrating nests and fascicles of histiocytoid to spindled cells, with some separation of nests by collagen bands. Both CNT and PFHT were uniformly positive for NKIC3 and CD10, and both were frequently PAX2 positive. MiTF was strongly and diffusely positive in CNT and was consistently negative in the PFHT. CONCLUSIONS: CNT and PFHT share many histopathologic features and immunohistochemical staining patterns. Of the stains we evaluated, we found that expression of MiTF may be a reliable marker for distinguishing CNT from histiocytoid-predominant PFHT, especially in instances where only a small part of the tumor is sampled for evaluation.
Subject(s)
Biomarkers, Tumor/analysis , Microphthalmia-Associated Transcription Factor/biosynthesis , Neurofibroma, Plexiform/diagnosis , Neurothekeoma/diagnosis , Skin Neoplasms/diagnosis , Adolescent , Adult , Aged , Biopsy , Child , Child, Preschool , Diagnosis, Differential , Female , Humans , Immunohistochemistry , Male , Microphthalmia-Associated Transcription Factor/analysis , Middle Aged , Neurofibroma, Plexiform/metabolism , Neurothekeoma/metabolism , Skin Neoplasms/metabolism , Young AdultABSTRACT
BACKGROUND: Cellular neurothekeoma (CNT) is a benign cutaneous mesenchymal neoplasm. Most demonstrate a lobulated to micronodular architecture. Rarely, CNT demonstrates a predominantly fascicular growth pattern, without prominent sclerosis and thus can mimic cellular dermatofibroma (DF). METHODS: Three CNT with a predominantly fascicular pattern were obtained. The clinicopathologic features and accompanying immunohistochemical stains were evaluated. RESULTS: All cases demonstrated a moderately cellular proliferation of epithelioid to spindle cells with pale to eosinophilic slightly granular cytoplasm, vesicular nuclei, and a single nucleolus arranged in a fascicular pattern with thick collagen bundles at the periphery (collagen trapping). One case had prominent epidermal hyperplasia. The neoplastic cells expressed NKI-C3, CD10, and micropthalmia transcription factor and lacked expression of factor XIIIa, S-100, epithelial membrane antigen, and CD34. CONCLUSIONS: Our cases showed an unusual pattern of CNT with a predominantly fascicular growth pattern, thickened collagen bundles at the periphery, and occasionally epidermal hyperplasia. The overlap with cellular DF is striking. The presence of plump to epithelioid cytomorphology with abundant cytoplasm, with focally prominent nucleoli; the presence of focal lobulated to micronodular growth pattern along with micropthalmia transcription factor positivity; and lack of factor XIIIa expression are helpful in distinguishing fascicular CNT from cellular DFs.
Subject(s)
Histiocytoma, Benign Fibrous/pathology , Neurothekeoma/pathology , Skin Neoplasms/pathology , Adult , Diagnosis, Differential , Female , Histiocytoma, Benign Fibrous/metabolism , Humans , Immunohistochemistry , Male , Middle Aged , Neurothekeoma/metabolism , Skin Neoplasms/metabolismABSTRACT
Cystic fibrosis transmembrane conductance regulator (CFTR) represents a cAMP-dependent channel found in normal apocrine glands. The classification and histogenesis of extra-mammary Paget's disease (EMPD) remains controversial, but it is generally accepted that primary EMPD exhibits apocrine differentiation. Therefore, we examined the utility of CFTR in the differential diagnosis of EMPD and squamous cell carcinoma in situ (SCCIS). Twenty-five cases of SCCIS and 14 cases of EMPD were evaluated for immunohistochemical expression of CFTR. Expression was scored as 0 (<5% of cells positive), 1+ (5-75% of cells positive) or 2+ (>75% cells positive). Twenty-three of 25 cases of SCCIS showed no reactivity for CFTR, and the remaining 2 cases showed 1+ staining. Thirteen of 14 cases of EMPD showed 2+ staining, while 1 case showed 1+ staining. We recognize that the pathological appearance along with clinical history and site of occurrence are sufficient to distinguish EMPD and SCCIS in most instances. However, distinction between the two can become more challenging when the location and histopathology are not characteristic. We conclude that when an immunohistochemical panel is diagnostically necessary, the expression of CFTR favors a diagnosis of EMPD over SCCIS.
Subject(s)
Biomarkers, Tumor/analysis , Bowen's Disease/diagnosis , Carcinoma in Situ/diagnosis , Cystic Fibrosis Transmembrane Conductance Regulator/analysis , Paget Disease, Extramammary/diagnosis , Skin Neoplasms/diagnosis , Adult , Aged , Aged, 80 and over , Cystic Fibrosis Transmembrane Conductance Regulator/biosynthesis , Diagnosis, Differential , Female , Humans , Immunohistochemistry , Male , Middle AgedABSTRACT
Metastasis stemming from a distant malignancy is far less common than an oropharyngeal primary and represents only 1% of all oral neoplasms. The difficulty in diagnosing a metastasis in the oropharynx may be compounded if the lesion is poorly differentiated and bears little resemblance to the primary tumor. We present the case of synchronous metastatic renal cell carcinoma of the mandibular gingiva in a woman with sarcomatoid clear cell renal cell carcinoma. The metastatic lesion was poorly differentiated and lacked expression of the renal cell carcinoma (RCC) antigen. In contrast, PAX-8 staining was strongly positive. This case serves to highlight the diagnostic difficulty posed by poorly differentiated lesions in the oropharynx and reinforces the sensitivity of the cell lineage-specific transcription factor PAX-8 in poorly differentiated RCC.
Subject(s)
Carcinoma, Renal Cell/pathology , Kidney Neoplasms/pathology , Oropharyngeal Neoplasms/pathology , Oropharyngeal Neoplasms/secondary , Carcinoma, Renal Cell/metabolism , Cell Differentiation , Diagnosis, Differential , Female , Gene Expression Regulation, Neoplastic , Humans , Kidney Neoplasms/metabolism , Middle Aged , Neoplasm Metastasis , Neoplasm Proteins , Oropharyngeal Neoplasms/metabolism , PAX8 Transcription Factor , Paired Box Transcription Factors/biosynthesisABSTRACT
BACKGROUND: Perineuriomas are an uncommon group of tumors composed of perineurial cells of peripheral nerve sheath lineage. Variants include soft tissue (extraneural), intraneural, sclerosing, reticular and plexiform forms. Sclerosing perineuriomas have been reported to occur almost exclusively on the hands of young men. Herein, we report three extra-acral cutaneous/soft tissue perineuriomas that show significant associated sclerosis. METHODS: Skin biopsy specimens from three patients were evaluated for cytomorphology and degree of associated sclerosis, which was classified as either focal or diffuse. Immunohistochemical expression of epithelial membrane antigen (EMA), CD34 and S-100 was also assessed to facilitate further classification. RESULTS: Histopathologically, the tumors showed both focal and diffuse sclerosis, and lesional cells were generally spindled in shape. Immunohistochemical staining showed diffuse positivity for CD34 and focal or diffuse positivity for EMA. The cells uniformly lacked expression of S-100 protein. CONCLUSIONS: Sclerosing perineuriomas can occur in extra-acral locations and should be considered in the differential of EMA-positive cutaneous spindle-cell proliferations. It is also important to recognize that perineuriomas can express CD34 and should be considered in the differential diagnosis of CD34-positive cutaneous neoplasms.
Subject(s)
Nerve Sheath Neoplasms/pathology , Skin Neoplasms/pathology , Soft Tissue Neoplasms/pathology , Aged, 80 and over , Antigens, CD34/metabolism , Biomarkers, Tumor/analysis , Diagnosis, Differential , Female , Humans , Immunohistochemistry , Middle Aged , Mucin-1/metabolism , Nerve Sheath Neoplasms/metabolism , Skin Neoplasms/metabolism , Soft Tissue Neoplasms/metabolismABSTRACT
Atypical fibroxanthoma (AFX), spindle cell squamous cell carcinoma (SCSCC) and spindle cell melanoma are the primary entities in the differential diagnosis of a cytologically atypical spindle cell tumor arising on sun-damaged skin. AFX is generally regarded as a diagnosis of exclusion in this context: in the absence of S100 or keratin reactivity, a diagnosis of AFX is favored. However, keratin reactivity may be focal or even absent in SCSCC, and although numerous positive markers of AFX have been proposed, none has shown sufficient sensitivity and specificity for routine diagnostic use. We evaluated 20 AFX and 10 SCSCC with a panel of cytokeratins and p63 to assess the utility of the latter antibody in this differential diagnosis. All 10 SCSCC showed strong expression of p63, whereas all 20 AFX were p63 negative. Two additional cases (excluded from the study) were negative for keratins and S100 on initial shave biopsies, resulting in a favored diagnosis of AFX, but p63 stains performed retrospectively were positive. However, review of the excision specimens in both cases revealed deep subcutaneous extension, excluding AFX. p63 reactivity argues against the diagnosis of AFX and is therefore a useful addition to the standard immunohistochemical panel for cutaneous spindle cell neoplasms.
Subject(s)
Biomarkers, Tumor/analysis , Carcinoma, Squamous Cell/diagnosis , Histiocytoma, Benign Fibrous/diagnosis , Membrane Proteins/metabolism , Skin Neoplasms/diagnosis , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/metabolism , Diagnosis, Differential , Female , Histiocytoma, Benign Fibrous/metabolism , Humans , Immunohistochemistry , Keratins/metabolism , Male , Middle Aged , S100 Proteins/biosynthesis , Skin Neoplasms/metabolismABSTRACT
Sebaceous carcinoma (SC) is an uncommon neoplasm that usually presents as an ocular or extraocular cutaneous lesion of the head and neck. We report a case of an 83-year-old woman with SC of the nipple. To our knowledge, this is the first report of SC arising in the nipple.
Subject(s)
Adenocarcinoma, Sebaceous/pathology , Breast Neoplasms/pathology , Nipples/pathology , Adenocarcinoma, Sebaceous/surgery , Aged, 80 and over , Breast Neoplasms/surgery , Disease-Free Survival , Female , Humans , Nipples/surgery , Treatment OutcomeABSTRACT
BACKGROUND: The histologic diagnosis of myeloid leukemia cutis (LC) can be difficult, requiring confirmatory immunohistochemical stains. OBJECTIVE: We reviewed 21 biopsy-proven cases of LC with emphasis on the use of immunohistochemistry in the diagnosis. MATERIALS AND METHODS: Clinical and histologic features were reviewed on 21 cases of biopsy proven LC. Immunohistochemical stains for CD4, CD34, CD56, CD68, CD117, CD123, TdT, lysozyme and myeloperoxidase were performed on 12 with available tissue blocks. RESULTS: Ages ranged from 24 to 88 years (mean = 57), with 12 men: 9 women. Primary hematologic diagnoses included acute myeloid leukemia (n = 14), myelodysplastic syndrome (n = 3), essential thrombocythemia (n = 1) and myeloid leukemia, NOS (n = 3). Monocytic myeloid LC was most common (35%). There was 100% positivity with CD68 and lysozyme. Myeloperoxidase, CD117 and CD34 immunostains were less sensitive in myeloid LC (58%, 33% and 17%, respectively). CD4 was positive in 67%. CD56 was positive in 33%. CONCLUSION: Myeloid leukemia with monocytic differentiation more commonly involves the skin than other types of myeloid leukemia. CD68 and lysozyme immunostains, although not lineage specific for monocytes/macrophages, are the most sensitive immunostains in the detection of myeloid LC. Myeloperoxidase immunostains are useful, but immunostains for CD117 and CD34 are insufficiently sensitive. CD4 expression is common, but CD56 expression is not.
Subject(s)
Biomarkers, Tumor/analysis , Leukemia, Myeloid/diagnosis , Leukemia, Myeloid/metabolism , Skin Neoplasms/diagnosis , Skin Neoplasms/metabolism , Adult , Aged , Aged, 80 and over , Antigens, CD/metabolism , DNA Nucleotidylexotransferase/metabolism , Female , Humans , Immunohistochemistry , Male , Middle Aged , Muramidase/metabolism , Peroxidase/metabolismABSTRACT
We report a case of a 68-year-old man with cutaneous leiomyosarcoma of the penis. Leiomyosarcoma of the penis is an extremely rare neoplasm that usually presents in middle to old age, and to our knowledge only approximately 30 cases have been reported in the literature to date. This is an important diagnosis in the differential diagnosis of cutaneous spindle cell neoplasms of the male genital tract.
Subject(s)
Leiomyosarcoma/diagnosis , Penile Neoplasms/diagnosis , Sarcoma/diagnosis , Skin Neoplasms/diagnosis , Actins/analysis , Aged , Biomarkers, Tumor/analysis , Diagnosis, Differential , Humans , Leiomyosarcoma/chemistry , Leiomyosarcoma/surgery , Male , Penile Neoplasms/chemistry , Penile Neoplasms/surgery , Treatment OutcomeABSTRACT
We report a case of a 75-year-old man with a cutaneous CD4+CD56+ hematodermic neoplasm. CD4+CD56+ hematodermic neoplasms are rare and commonly present as cutaneous lesions. This is an important diagnosis in the differential diagnosis of cutaneous hematologic malignancies because of the extremely poor prognosis.
Subject(s)
CD4 Antigens/metabolism , CD56 Antigen/metabolism , Hematologic Neoplasms/diagnosis , Skin Neoplasms/diagnosis , Aged , Diagnosis, Differential , Hematologic Neoplasms/immunology , Hematologic Neoplasms/pathology , Humans , Male , Prognosis , Skin Neoplasms/immunology , Skin Neoplasms/pathologyABSTRACT
The prognosis and therapy for dysgerminomas are different from those of other ovarian tumor types, making accurate diagnosis imperative for patient care. OCT4 (POU5F1) is a transcription factor involved in the regulation of pluripotency during embryonic development. It can be detected in both pluripotent cells and other early germ cells. This study examines the expression of OCT4 in both dysgerminoma and nondysgerminomatous neoplasms involving the ovary. Formalin-fixed, paraffin-embedded cell blocks of 33 cases of dysgerminoma including 2 cases of gonadoblastoma associated with dysgerminoma and 3 cases of metastatic dysgerminoma, and 111 cases of nondysgerminomatous neoplasms involving the ovary were stained using the antibody against OCT4. All cases of dysgerminomas and gonadoblastomas were positive for OCT4 with strong nuclear staining. More than 90% of dysgerminoma cells in each case showed diffuse strong nuclear staining. In addition, 3 metastatic dysgerminomas also showed uniform strong nuclear staining. All nondysgerminomatous tumors (mature teratoma, 14; yolk sac tumor, 4; Sertoli-Leydig cell tumor, 15; granulosa cell tumor, 22; Brenner tumor, 3; carcinoid tumor, 4; struma ovarii, 2; fibroma, 5; thecoma, 1; serous adenocarcinoma, 5; endometrioid adenocarcinoma, 4; small cell carcinoma, 6; stromal sarcoma, 1; malignant lymphoma, 6; metastatic malignant melanoma, 1; metastatic carcinoid, 2; metastatic small cell carcinoma, 1; and metastatic lobular carcinoma of the breast, 1) were negative for OCT4, except for some cases of clear cell adenocarcinoma of the ovary. Four of 14 clear cell adenocarcinomas showed focal positive nuclear immunoreactivity for OCT4. OCT4 is a sensitive and relatively specific biomarker for the detection of dysgerminoma. It may also be useful in the diagnosis of gonadoblastoma, which contains similar cells and may be associated with dysgerminoma. OCT4 may aid in the detection of small foci of metastatic dygerminoma in extraovarian sites and may also help distinguish dysgerminoma from other primary and metastatic tumors of the ovary.